Natural Alternatives International (NASDAQ:NAII) Receives New Coverage from Analysts at StockNews.com

Analysts at StockNews.com started coverage on shares of Natural Alternatives International (NASDAQ:NAII) in a research note issued to investors on Wednesday. The brokerage set a “buy” rating on the stock.

Separately, TheStreet downgraded shares of Natural Alternatives International from a “c” rating to a “d” rating in a research report on Tuesday, February 13th.

Natural Alternatives International Trading Down 2.0 %

Shares of NAII stock opened at $6.37 on Wednesday. Natural Alternatives International has a 1 year low of $5.06 and a 1 year high of $9.44. The stock has a market cap of $38.79 million, a P/E ratio of -9.10 and a beta of 0.58. The company has a current ratio of 4.06, a quick ratio of 2.59 and a debt-to-equity ratio of 0.11. The stock has a 50 day simple moving average of $6.19 and a 200 day simple moving average of $6.24.

Natural Alternatives International (NASDAQ:NAII) last announced its quarterly earnings data on Tuesday, February 13th. The company reported ($0.52) EPS for the quarter. Natural Alternatives International had a negative net margin of 3.22% and a negative return on equity of 4.70%. The firm had revenue of $25.20 million for the quarter.

About Natural Alternatives International

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.